Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1965 1
1966 1
1967 1
1969 1
1970 1
1971 1
1972 1
1973 1
1974 1
1975 1
1984 1
1985 2
1988 3
1989 2
1990 1
1991 2
1992 1
1994 1
1996 3
1997 1
1998 1
1999 1
2000 1
2001 2
2002 4
2003 3
2004 6
2005 10
2006 8
2007 5
2008 12
2009 9
2010 4
2011 3
2012 3
2013 10
2014 7
2015 7
2016 7
2017 11
2018 10
2019 12
2020 7
2021 10
2022 5
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

167 results

Results by year

Filters applied: . Clear all
Page 1
Evidence-based practice in times of drug shortage.
de Lemos ML, Waignein S, de Haan M. de Lemos ML, et al. J Oncol Pharm Pract. 2016 Jun;22(3):566-70. doi: 10.1177/1078155215589980. Epub 2015 Jun 4. J Oncol Pharm Pract. 2016. PMID: 26044588 Review.
Mavoglurant as a treatment for Parkinson's disease.
Petrov D, Pedros I, de Lemos ML, Pallàs M, Canudas AM, Lazarowski A, Beas-Zarate C, Auladell C, Folch J, Camins A. Petrov D, et al. Among authors: de lemos ml. Expert Opin Investig Drugs. 2014 Aug;23(8):1165-79. doi: 10.1517/13543784.2014.931370. Epub 2014 Jun 24. Expert Opin Investig Drugs. 2014. PMID: 24960254 Review.
Defining cytotoxic drugs - you know it when you see it?
de Lemos ML, Badry N, Conklin J, Koberinski M. de Lemos ML, et al. J Oncol Pharm Pract. 2021 Dec;27(8):1958-1962. doi: 10.1177/10781552211034473. Epub 2021 Sep 24. J Oncol Pharm Pract. 2021. PMID: 34558361 Review.
Management of extravasation of oxaliplatin.
de Lemos ML, Walisser S. de Lemos ML, et al. J Oncol Pharm Pract. 2005 Dec;11(4):159-62. doi: 10.1191/1078155205jp165oa. J Oncol Pharm Pract. 2005. PMID: 16595069 Review.
167 results